Teva Pharmaceutical Industries Limited
TEVA | NYSE
$39.47
-$0.59 (-1.47%)
Sep 22, 2026, 2:37 PM ET · Market open
Market Data
Market Cap $46.66B
Enterprise Value $59.87B
Beta 0.87
Average Volume 6.06M
Shares Outstanding (Diluted) 1.18B
Shares Change YoY 1.72%
Institutional Ownership 58.28%
Exchange NYSE
ISIN US8816242098
Price Performance
Price Change 1M 7.3%
Price Change 3M 20.6%
Price Change 6M 36.0%
Price Change YTD 29.4%
Price Change 1Y 112.3%
Price Change 3Y 287.1%
Price Change 5Y 347.6%
1M CAGR (ann.) 13.3%
1Y CAGR (ann.) 117.1%
5Y CAGR (ann.) 34.0%
All-Time CAGR 2.3%
Valuation
PE Ratio 66.77
Forward PE 12.80
PEG Ratio 0.12
Forward PEG 1.16
PS Ratio 2.69
Forward PS 2.70
PB Ratio 6.01
P/FCF Ratio 31.24
P/Adj. FCF Ratio 34.16
P/OCF Ratio 15.90
EV/Sales 3.46
EV/EBIT 29.73
EV/EBITDA 19.88
EV/FCF 40.09
Earnings Yield 1.5%
FCF Yield 3.2%
Adj. FCF Yield 2.9%
Financial Health
Net Debt $12.94B
Total Debt $16.87B
Cash & Short-Term Investments $3.66B
Total Assets $39.86B
Current Ratio 0.88
Quick Ratio 0.67
Debt / Equity Ratio 2.16
Debt / EBITDA 5.60
Debt / FCF 11.30
OCF / Debt 0.12
Interest Coverage 2.99
Altman Z-Score 0.93
Piotroski F-Score 7
Margins & Profitability
Gross Profit Margin 52.5%
Operating Profit Margin 11.4%
EBITDA Margin 17.7%
Net Profit Margin 4.1%
FCF Margin 8.6%
Adj. FCF Margin 7.9%
SBC / Revenue 0.7%
SBC Impact (per share) -8.6%
Returns
Return on Assets 1.8%
Return on Equity 9.2%
Return on Invested Capital 9.0%
Return on Capital Employed 10.7%
Return on Tangible Assets 3.5%
Historical Growth (CAGR)
Revenue CAGR 3Y 4.9%
Revenue CAGR 5Y 1.2%
Revenue CAGR 10Y -1.2%
EPS CAGR 3Y 2970.0%
EPS CAGR 5Y 84.9%
EPS CAGR 10Y -9.2%
FCF CAGR 3Y 8.4%
FCF CAGR 5Y 18.6%
FCF CAGR 10Y -10.0%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 46
EPS Growth Next 3Y 82.7%
Revenue Growth Next 3Y 3.2%
Earnings Date Nov 3, 2026
EPS Estimate (next Q) $0.70
EPS Growth Est (next Q) -10.4%
Revenue Est (next Q) $4.26B
Revenue Growth Est (next Q) -5.0%
Fair Value Estimates
Graham Number $9.48
Graham Upside -76.3%
Lynch Fair Value $15
Lynch Upside -62.6%
Price Target $44.75
Price Target Upside 11.7%
Cash Flow
Operating Cash Flow $2.05B
Free Cash Flow $1.49B
Adj. Free Cash Flow $1.37B
FCF Per Share $2.04
OCF Per Share $2.52
OCF/S Ratio 16.9%
Income Statement
Revenue $17.31B
Gross Profit $9.09B
Operating Income $1.98B
EBITDA $3.01B
Net Income $706M
EPS (Diluted) $0.60
Revenue / Employee $540.93K
Profit / Employee $22.06K
Employees 32,008
Add to Watchlist
Select watchlists to add or remove TEVA